Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute Decompensated Heart Failure
Completed
Cumberland Pharmaceuticals
Phase 2
2002-11-01
This is a randomized, double-blind, placebo-controlled, dose ranging pilot study to examine
the effects of conivaptan in patients with acute decompensated heart failure.
An Open-Label Study of YM087 (Conivaptan) in Patients With Euvolemic or Hypervolemic Hyponatremia
Completed
Cumberland Pharmaceuticals
Phase 3
2004-02-01
This study will investigate the application of a vasopressin antagonist in the treatment of
hyponatremia most likely caused by inappropriate AVP secretion. The population studied will
include patients with euvolemic or hypervolemic hyponatremia.
A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia
Completed
Cumberland Pharmaceuticals
Phase 4
2007-01-01
The study will evaluate the effectiveness and safety of multiple dosing regimens of IV
conivaptan in subjects with euvolemic or hypervolemic hyponatremia
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
